Digital Angel Corporation gets a wide recognize for its syringe-implantable glucose-sensing RFID microchip from none other than the US Patent and Trade Office this week.
It is a good piece of news for the diabetics who can now more closely monitor their glucose levels without finger pricks. For which, they have to purchase a RFID microchip of Digital Angel. VeriChip, a division of Digital Angel will distribute and market these RFID chips in US.
As predicted, a glucose-sensing microchip could profoundly affect the 230 million people worldwide living with diabetes. In the wake of this, the patent approval for this RFID microchip is a major step in bringing this life-altering technology to market, explains Kevin McGrath, the company’s CEO and President.
